0001140361-19-020486.txt : 20191113 0001140361-19-020486.hdr.sgml : 20191113 20191113203108 ACCESSION NUMBER: 0001140361-19-020486 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191108 FILED AS OF DATE: 20191113 DATE AS OF CHANGE: 20191113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CALIFORNIA CENTRAL INDEX KEY: 0000315054 STATE OF INCORPORATION: CA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 191215954 BUSINESS ADDRESS: STREET 1: 1111 BROADWAY STREET 2: 21ST FLOOR CITY: OAKLAND STATE: CA ZIP: 94607-4026 BUSINESS PHONE: 510-987-9600 MAIL ADDRESS: STREET 1: 1111 BROADWAY STREET 2: 21ST FLOOR CITY: OAKLAND STATE: CA ZIP: 94607-4026 FORMER NAME: FORMER CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CA DATE OF NAME CHANGE: 19600201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4/A 1 form4.xml FORM 4/A X0306 4/A 2019-11-08 2019-11-12 true 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0000315054 REGENTS OF THE UNIVERSITY OF CALIFORNIA 1111 BROADWAY, SUITE 2100 OAKLAND CA 94607 true Common Stock 2019-11-08 4 S 0 100000 30.25 D 2197406 D Common Stock 2019-11-08 4 S 0 74316 30.44 D 2123090 D Common Stock 2019-11-12 4 S 0 12800 32.77 D 2110290 D Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D). Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090. Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290. /s/ Arthur R. Guimaraes 2019-11-13